Discover 1,239 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,239
Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica
for
Polymyalgia Rheumatica
Location: Murfreesboro TN, Jackson TN, Cumming GA, Gainesville GA,
Sponsor: Sanofi
Sex: All
Age: 50+
Code: NCT07286214
Phase 3, Recruiting
New
Phase 3 Study of Denifanstat in Participants With Moderate to Severe Acne (AURORA)
for
Acne Vulgaris
Location: Murfreesboro TN, New Albany IN, Greenville SC,
Sponsor: Sagimet Biosciences Inc.
Sex: All
Age: 12+
Code: NCT07863193
Phase 3, Recruiting
Active & Responsive
A Study of YL201 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Nashville TN, St Louis MO, Chapel Hill NC, Ann Arbor MI,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All
Age: 18+
Code: NCT05434234
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC
for
Primary Sclerosing Cholangitis (PSC)
Location: Nashville TN, Iowa City IA, Baltimore MD, Seattle WA
Sponsor: LISCure Biosciences
Sex: All
Age: 18 - 70+
Code: NCT06699121
Phase 2, Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan
for
Solid Tumors Harboring MET Amplification
Location: Nashville TN, Chicago IL, Durham NC, Grand Rapids MI,
Sponsor: AbbVie
Sex: All
Age: 12+
Code: NCT07196644
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
FeaturedActive & Responsive
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
for
Generalized Anxiety Disorder (GAD)
Location: Franklin TN, Huntsville AL, Marietta GA, Cincinnati OH,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT06846320
Phase 2, Recruiting
Embo Registry; National Registry for Artery Embolization
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
for
Cardiovascular Disease
Location: Tullahoma TN, Bowling Green KY, Athens AL,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07000357
Phase 3, Recruiting
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
A Tailored, Health Communication Intervention for HPV Vaccine Hesitant Families
for
Human Papilloma Virus, HPV-Related Carcinoma, Vaccine Refusal,
Location: Nashville TN
Sponsor: Meharry Medical College
Sex: All
Age: 18+
Code: NCT04380623
Recruiting
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)